Susquehanna International Group, LLP Roivant Sciences Ltd. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.17 - $12.5 $1.56 Million - $1.92 Million	-153,200 Reduced 29.44%	367,200 $4.24 Million
Q2 2024 Aug 15, 2024	BUY	$10.36 - $11.74 $1.19 Million - $1.35 Million	115,000 Added 28.37%	520,400 $5.5 Million
Q1 2024 May 07, 2024	SELL	$9.87 - $11.8 $8.8 Million - $10.5 Million	-891,100 Reduced 68.73%	405,400 $4.27 Million
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $7.36 Million - $10.2 Million	878,100 Added 209.87%	1,296,500 $14.6 Million
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $1.34 Million - $1.82 Million	137,700 Added 49.06%	418,400 $4.89 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $900,430 - $1.28 Million	127,000 Added 82.63%	280,700 $2.83 Million
Q1 2023 May 16, 2023	BUY	$6.92 - $9.98 $85,808 - $123,752	12,400 Added 8.78%	153,700 $1.13 Million
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $474,768 - $1.13 Million	141,300 New	141,300 $1.13 Million

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.95B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.